This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Obesity Drugs: Orexigen Gains Market Share at Expense of Arena, Vivus

02/20/15 - 03:47 PM EST

The U.S. launch of Orexigen's obesity pill Contrave is outpacing the competition.

READ FULL POST

Achillion: Hep C Drug Discounting May Hurt Our Market Value, Stock Price

02/11/15 - 09:04 AM EST

Achillion Pharmaceuticals announced a 10 million-share stock offering Tuesday night.

READ FULL POST

Well-Fed Analysts Stay Mum on Keryx Biopharma's Slow Drug Launch

02/09/15 - 08:36 AM EST

Keryx Biopharmaceuticals gave all 12 of the investment banks with research coverage of the company a slice of its $110 million stock offering.

READ FULL POST

Isis Pharma Time Shifts Diabetes Drug Trial to Embellish Results

02/03/15 - 07:59 AM EST

An experimental diabetes drug from Isis looks good when the effect is measured at 36 weeks, but the study was designed to measure the end point at 27 weeks.

READ FULL POST

Gilead: Hepatitis C Sales Guidance for 2015 Focus of Tuesday's Earnings Report

02/02/15 - 12:22 PM EST

Gilead Sciences reports fourth-quarter and 2014 earnings on Tuesday after the market close.

READ FULL POST

Dendreon's Asset Rummage Sale Completes the Circle of Life

01/30/15 - 06:01 AM EST

Valeant Pharmaceuticals is in a tentative deal to acquire the assets of Dendreon -- mostly its prostate-cancer vaccine Provenge and manufacturing facilities -- for $296 million in cash.

READ FULL POST

The Absurdity of Flex Pharma IPO: 2 Spices and a Veg Net $86M

01/29/15 - 07:44 AM EST

If the biotech bull market hasn't reached 11 on the absurdity meter quite yet, the Flex Pharma FLKS IPO gets us close.

READ FULL POST

Aegerion Target of SEC Probe Related to Drug Sales Practices

01/13/15 - 09:12 AM EST

Aegerion slipped disclosure of the SEC probe into an regulatory filing last night.

READ FULL POST

Bristol-Myers Checkpoint Inhibitor Prolongs Lung Cancer Patient Survival

01/12/15 - 07:07 AM EST

Lung cancer is a larger commercial market opportunity for Bristol's Opdivo and Merck's Keytruda.

READ FULL POST

'Free the Webcast!' Investor Transparency Gains Momentum at 'JPM15' Healthcare Confab

01/09/15 - 02:56 PM EST

Following a week of awareness raising through phone calls, Twitter and a Loncar guest appearance on CNBC, the number of JPM breakout session webcasts has increased significantly.

READ FULL POST

Markets

DOW 17,928.20 -142.20 -0.79%
S&P 500 2,089.46 -25.03 -1.18%
NASDAQ 4,939.3270 -77.6020 -1.55%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs